NuvemRx, a leading tech-enabled pharmacy solutions company for community health providers, today announced it has acquired ...

R1 RCM expects the Ascension ransomware attack to drag down its revenue by between $75 million and $95 million in 2024, primarily because of a delay in timing of revenue from the second half of 2024 ...

MURRAY, Utah, June 17, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial ...

R1 RCM has received a noncompliance notice from Nasdaq’s Listing Qualifications Department resulting from R1’s delay in filing its quarterly report on Form 10-Q for the third quarter of 2023. Nasdaq’s ...

MURRAY, Utah, Nov. 02, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare ...

Leerink Partners analyst Michael Cherny reiterated a Buy rating on R1 RCM (RCM – Research Report) on March 7 and set a price target of $17.00. Michael Cherny has given his Buy rating due to a ...

MURRAY, Utah, Dec. 06, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of ...

(Reuters) -R1 RCM said on Thursday private-equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R) would acquire the healthcare technology company in a deal that values it at $8.9 ...

Voss Capital, LLC an investment management company, released its first-quarter 2024 investor letter. A copy of the letter can be downloaded here. Voss Capital’s funds, Voss Value Fund, LP, and the ...